Signaling network inhibition by selected traditional Chinese medicine preparations: a novel multi-target paradigm for colorectal cancer therapy
Frontiers in Pharmacology · 09.02.2026 · 17
DOI: 10.3389/fphar.2026.1719306 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 09.02.2026. Verfasst von Mingming Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Tuina Department, The First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Colorectal cancer (CRC) remains a significant global health burden, with drug resistance, recurrence, and metastasis posing major therapeutic challenges. Traditional Chinese Medicine (TCM), employing a holistic “multi-component, multi-target, multi-pathway” strategy, offers a promising complementary approach. This review systematically summarizes recent advances in how TCM monomers and formulations regulate key CRC signaling pathways—including PI3K/Akt/mTOR, MAPK, Wnt/β-catenin, Hedgehog, and NF-κB—to inhibit tumor proliferation, promote apoptosis, suppress metastasis, and remodel the tumor microenvironment. Emphasis is placed on TCM’s unique modulation of pathway crosstalk, providing new insights into its ability to reverse drug resistance and enhance chemosensitivity. The review further proposes and discusses the future translational potential of TCM-based “signaling network inhibitors” as an innovative strategy in CRC management.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Tuina Department, The First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin, China.
- Graduate School of Heilongjiang University of Traditional Chinese Medicine, Harbin, China.
Zitieren
APA
Zhang, M., Wang, H., Pan, J., Jin, Y., & Tan, Z. (2026). Signaling network inhibition by selected traditional Chinese medicine preparations: a novel multi-target paradigm for colorectal cancer therapy. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1719306
Vancouver
Zhang M, Wang H, Pan J, Jin Y, Tan Z. Signaling network inhibition by selected traditional Chinese medicine preparations: a novel multi-target paradigm for colorectal cancer therapy. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1719306
BibTeX
@article{Zhang2026,
author = {Zhang, Mingming and Wang, Haoyang and Pan, Junying and Jin, Yuzhe and Tan, Zengde},
title = {Signaling network inhibition by selected traditional Chinese medicine preparations: a novel multi-target paradigm for colorectal cancer therapy},
journal = {Frontiers in Pharmacology},
year = {2026},
volume = {17},
doi = {10.3389/fphar.2026.1719306}
}
EUVIMED